AI assistant
HARVARD BIOSCIENCE INC — Director's Dealing 2024
Mar 7, 2024
34975_dirs_2024-03-07_0e4c3158-e8d8-4f4f-adb8-54e8be192c88.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2024-03-05
Reporting Person: Green James W (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-03-05 | Common Stock | A | 214797 | $0.00 | Acquired | 2866294 | Direct |
| 2024-03-05 | Common Stock | A | 214797 | $0.00 | Acquired | 3081091 | Direct |
Footnotes
F1: Represents an award of restricted stock units ("RSUs") that will vest in three equal installments on March 19, 2025, 2026, and 2027.
F2: The number of RSUs represents the target number of RSUs that may be earned based on achievement by the Company of certain performance criteria. The actual number of RSUs awarded may vary between 0% and 150% of the target, depending on the Company's performance. The performance period will end on December 31, 2026.
F3: Includes (a) the awards described in footnotes (1) and (2) above, (b) 235,427 RSUs that will vest in two equal installments on December 29, 2024 and 2025, (c) 52,346 RSUs that will vest on December 29, 2024, (d) 484,975 RSUs with performance based vesting conditions tied to relative total shareholder return and (e) 1,878,749 shares of common stock beneficially owned by the Reporting Person.